Healthcare provider profile · identity verified

Tracy A Mizeur, M.D.

Family Practice · LINCOLN, IL · NPI 1467427716

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	550	140
Lisinopril	Lisinopril	420	95
Levothyroxine Sodium	Levothyroxine Sodium	308	72
Amlodipine Besylate	Amlodipine Besylate	303	75
Metformin Hcl Er	Metformin Hcl	245	58
Potassium Chloride	Potassium Chloride	242	57
Pantoprazole Sodium	Pantoprazole Sodium	232	54
Furosemide	Furosemide	221	52
Hydrochlorothiazide	Hydrochlorothiazide	212	48
Trazodone Hcl	Trazodone Hcl	200	39
Gabapentin	Gabapentin	199	39
Citalopram Hbr	Citalopram Hydrobromide	184	34
Metoprolol Succinate	Metoprolol Succinate	183	50
Omeprazole	Omeprazole	160	43
Losartan Potassium	Losartan Potassium	158	37
Metoprolol Tartrate	Metoprolol Tartrate	155	30
Glipizide Er	Glipizide	148	36
Tramadol Hcl	Tramadol Hcl	148	45
Albuterol Sulfate Hfa	Albuterol Sulfate	132	38
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	129	27
Alendronate Sodium	Alendronate Sodium	123	37
Simvastatin	Simvastatin	122	23
Famotidine	Famotidine	116	33
Pravastatin Sodium	Pravastatin Sodium	116	27
Sertraline Hcl	Sertraline Hcl	115	26
Duloxetine Hcl	Duloxetine Hcl	104	20
Alprazolam	Alprazolam	97	33
Fluticasone Propionate	Fluticasone Propionate	97	28
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	96	34
Carvedilol	Carvedilol	95	19
Lovastatin	Lovastatin	88	19
Escitalopram Oxalate	Escitalopram Oxalate	86	16
Meloxicam	Meloxicam	83	22
Metformin Hcl	Metformin Hcl	79	18
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	78	19
Ozempic	Semaglutide	76	11
Eliquis	Apixaban	75	14
Clopidogrel	Clopidogrel Bisulfate	71	19
Montelukast Sodium	Montelukast Sodium	67	16
Allopurinol	Allopurinol	64	13
Esomeprazole Magnesium	Esomeprazole Magnesium	64	13
Atenolol	Atenolol	61	suppressed
Warfarin Sodium	Warfarin Sodium	61	suppressed
Bupropion Hcl Sr	Bupropion Hcl	60	14
Tamsulosin Hcl	Tamsulosin Hcl	59	suppressed
Lorazepam	Lorazepam	57	17
Venlafaxine Hcl Er	Venlafaxine Hcl	57	11
Fluoxetine Hcl	Fluoxetine Hcl	55	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	53	suppressed
Pregabalin	Pregabalin	53	12
Rosuvastatin Calcium	Rosuvastatin Calcium	53	15
Amitriptyline Hcl	Amitriptyline Hcl	49	suppressed
Spironolactone	Spironolactone	49	12
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	47	suppressed
Mirtazapine	Mirtazapine	47	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	46	29
Hydroxyzine Hcl	Hydroxyzine Hcl	44	16
Isosorbide Mononitrate Er	Isosorbide Mononitrate	44	11
Buspirone Hcl	Buspirone Hcl	43	suppressed
Cephalexin	Cephalexin	43	26
Amoxicillin	Amoxicillin	42	33
Paroxetine Hcl	Paroxetine Hcl	41	suppressed
Donepezil Hcl	Donepezil Hcl	40	suppressed
Ezetimibe	Ezetimibe	40	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	40	suppressed
Ropinirole Hcl	Ropinirole Hcl	40	suppressed
Trulicity	Dulaglutide	39	suppressed
Prednisone	Prednisone	38	22
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	35	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	34	13
Glimepiride	Glimepiride	31	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	31	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	31	suppressed
Enalapril Maleate	Enalapril Maleate	30	suppressed
Glipizide	Glipizide	30	suppressed
Klor-Con M20	Potassium Chloride	30	suppressed
Sucralfate	Sucralfate	28	suppressed
Divalproex Sodium	Divalproex Sodium	27	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	26	suppressed
Hydralazine Hcl	Hydralazine Hcl	26	suppressed
Topiramate	Topiramate	26	suppressed
Verapamil Er	Verapamil Hcl	26	suppressed
Acyclovir	Acyclovir	24	suppressed
Fenofibrate	Fenofibrate	24	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	22	17
Irbesartan	Irbesartan	21	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	21	suppressed
Levetiracetam	Levetiracetam	21	suppressed
Baclofen	Baclofen	20	suppressed
Ventolin Hfa	Albuterol Sulfate	20	suppressed
Azithromycin	Azithromycin	19	13
Januvia	Sitagliptin Phosphate	19	suppressed
Meclizine Hcl	Meclizine Hcl	19	suppressed
Propranolol Hcl	Propranolol Hcl	19	suppressed
Propranolol Hcl Er	Propranolol Hcl	19	suppressed
Tizanidine Hcl	Tizanidine Hcl	18	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	18	suppressed
Clonidine Hcl	Clonidine Hcl	17	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	17	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	17	suppressed
Fenofibrate	Fenofibrate,micronized	16	suppressed
Chlorthalidone	Chlorthalidone	15	suppressed
Diazepam	Diazepam	15	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	15	suppressed
Nystatin	Nystatin	15	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	14	14
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	13	11
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	13	suppressed
Glyburide	Glyburide	13	suppressed
Metaxalone	Metaxalone	13	suppressed
Celecoxib	Celecoxib	12	suppressed
Humalog Kwikpen U-200	Insulin Lispro	12	suppressed
Humulin 70-30	Insulin Nph Hum/Reg Insulin Hm	12	suppressed
Lurasidone Hcl	Lurasidone Hcl	12	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	12	suppressed
Ramipril	Ramipril	12	suppressed
Solifenacin Succinate	Solifenacin Succinate	12	suppressed
Torsemide	Torsemide	12	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	12	suppressed
Fluconazole	Fluconazole	11	suppressed
Klor-Con M10	Potassium Chloride	11	suppressed
Novolin 70-30 Flexpen	Insulin Nph Hum/Reg Insulin Hm	11	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error